Newsfeeds - Spark Newswire

2 minute read

FDA
News

PDS Biotechnology Says Expands VERSATILE-002 Study Of PDS0101, KEYTRUDA In Advanced Head And Neck Cancer To Include Patients Who Have Failed Prior Treatment With Checkpoint Inhibitors

Today, 3:55 PM

PDS Biotechnology Corporation (NASDAQ:PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company's proprietary Versamune® T-cell

MRK

5 minute read

The Daily Biotech Pulse: Merck Completes Organon Spin-Off, Auris Repositions As RNA Therapeutic Company With Trasir Purchase, Replimune’s Readout

By Shanthi Rexaline

Today, 3:55 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 2)

AMYT

7 minute read

The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes

By Shanthi Rexaline

Today, 3:55 PM

After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-specific news flow dictated stock moves during the week.

ADAP

1 minute read

News

Merck & Co To Remain In Dow Jones Industrial Average After Spin-Off Transaction

By Benzinga Newsdesk

Today, 3:55 PM

https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20210527-1385959/1385959_djiamrkspinjune2021.pdf

MRK

2 minute read

Boeing, Intel Lead The DIA Higher Thursday

By Henry Khederian

Today, 3:55 PM

U.S. indices were trading higher Thursday following better-than-expected U.S. jobless numbers as well as reports that President Joe Biden will propose a $6-trillion budget.

AMC

1 minute read

Uncategorized

NGM Stock Tumbles After Aldafermin Flunks In Mid-Stage NASH Study

By Vandana Singh

Today, 3:55 PM

NGM Biopharmaceuticals Inc (NASDAQ: NGM) has reported results from the 24-week Phase 2b ALPINE 2/3 study evaluating aldafermin in non-alcoholic steatohepatitis…

MRK

1 minute read

Uncategorized

Merck Receives a Positive European Union CHMP Opinion for KEYTRUDA in Combination with Chemotherapy as a First-Line Treatment for Esophageal Cancer

By Luke J Jacobi

Today, 3:55 PM

Recommendation Based on Significant Survival Benefit Demonstrated With KEYTRUDA Plus Chemotherapy Versus Chemotherapy in Phase 3 KEYNOTE-590 Trial

MRK

2 minute read

Uncategorized

Disney And Chevron Lead The Dow Jones Higher Friday

By Henry Khederian

Today, 3:55 PM

The market was mixed Friday as stocks continue to rebound following weakness earlier in the week. U.S. indices were trading lower earlier this week amid continued weakness in tech stocks as investors weigh the Fed's April minutes. Inflation and concerns of future rate hikes have also weighed on investor sentiment recently.

AAPL